[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know",
    "summary": "Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
    "url": "https://finnhub.io/api/news?id=b245d9ce9f44cdb5719fb11590d919b88c2e11b0ffc7bcaa3ad0640b7417b776",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763744403,
      "headline": "Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know",
      "id": 137572317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
      "url": "https://finnhub.io/api/news?id=b245d9ce9f44cdb5719fb11590d919b88c2e11b0ffc7bcaa3ad0640b7417b776"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound?",
    "summary": "Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=20cd1b4f2001a8cd2f1eb4b7738bcb0aae4ac861e44bfa7ce7d3720c37b1a38a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763742603,
      "headline": "Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound?",
      "id": 137572318,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=20cd1b4f2001a8cd2f1eb4b7738bcb0aae4ac861e44bfa7ce7d3720c37b1a38a"
    }
  },
  {
    "ts": null,
    "headline": "Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates",
    "summary": "VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.",
    "url": "https://finnhub.io/api/news?id=e9f47d7da1728d32e7c71cf41330c332c20e12c9f0ab59f25bff22e7f015b1a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763740380,
      "headline": "Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates",
      "id": 137572319,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.",
      "url": "https://finnhub.io/api/news?id=e9f47d7da1728d32e7c71cf41330c332c20e12c9f0ab59f25bff22e7f015b1a5"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Hold AngioDynamics Stock in Your Portfolio for Now",
    "summary": "ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.",
    "url": "https://finnhub.io/api/news?id=8e0671769c7a97b4a2dcf6e9ca138cfec91dbd46e4cb001cfbdfb2e04f98a5a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763740200,
      "headline": "Reasons to Hold AngioDynamics Stock in Your Portfolio for Now",
      "id": 137572320,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.",
      "url": "https://finnhub.io/api/news?id=8e0671769c7a97b4a2dcf6e9ca138cfec91dbd46e4cb001cfbdfb2e04f98a5a3"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Cencora, Inc. (COR) This Year?",
    "summary": "Here is how Cencora (COR) and Boston Scientific (BSX) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=8db5de5ad93b16ce575a17f7cdbbb67e823c33fec2103ccd02403c928ed845db",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763736002,
      "headline": "Are Medical Stocks Lagging  Cencora, Inc. (COR) This Year?",
      "id": 137572321,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Here is how Cencora (COR) and Boston Scientific (BSX) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=8db5de5ad93b16ce575a17f7cdbbb67e823c33fec2103ccd02403c928ed845db"
    }
  },
  {
    "ts": null,
    "headline": "LH Shares Gain Following Publication of New Plasma Detect MRD Data",
    "summary": "Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.",
    "url": "https://finnhub.io/api/news?id=cf3ceef15a1d9aedfb79fc4afba355fb6a2d8151d5350588d144aec362f2b18d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763730660,
      "headline": "LH Shares Gain Following Publication of New Plasma Detect MRD Data",
      "id": 137572322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.",
      "url": "https://finnhub.io/api/news?id=cf3ceef15a1d9aedfb79fc4afba355fb6a2d8151d5350588d144aec362f2b18d"
    }
  },
  {
    "ts": null,
    "headline": "BTIG Reiterates Boston Scientific (BSX) Buy Recommendation",
    "summary": "BTIG Reiterates Boston Scientific (BSX) Buy Recommendation",
    "url": "https://finnhub.io/api/news?id=323ec1c6d405217d98c714d9479c480e2d60fbb89d307dedea70589d02b52379",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763726577,
      "headline": "BTIG Reiterates Boston Scientific (BSX) Buy Recommendation",
      "id": 137568878,
      "image": "",
      "related": "BSX",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=323ec1c6d405217d98c714d9479c480e2d60fbb89d307dedea70589d02b52379"
    }
  }
]